Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
about
Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinomaVEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis.Signaling mechanisms in neuroendocrine tumors as targets for therapy.Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines.Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours.HGF percutaneous endocardial injection induces cardiomyocyte proliferation and rescues cardiac function in pigs.Accelerated repair and reduced mutagenicity of DNA damage induced by cigarette smoke in human bronchial cells transfected with E.coli formamidopyrimidine DNA glycosylase.Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumorsOverexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumorsThe molecular pathogenesis and management of bronchial carcinoids.Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.The role of cell lines in the study of neuroendocrine tumors.Profiling mTOR pathway in neuroendocrine tumors.MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.Expression of p-AKT and p-mTOR in a large series of bronchopulmonary neuroendocrine tumors.Pulmonary carcinoid: a rare thoracic malignancy, a high need for better defined systemic therapy.
P2860
Q28476794-EFF61A19-FA5E-4701-8A22-62E2BC7DC0EBQ33926020-6348D579-9239-4A19-B405-1D75FA104BE1Q34447484-4374667C-4455-4CBA-9398-4DF4795D985FQ34911416-3FA9C9BD-6976-4661-B366-F3A05FC3D86AQ36167254-382232D3-3264-415D-A41D-6708E98C75A5Q36642695-6B9BCA21-C32D-4766-AC65-A6FF14BBAD5AQ36681433-F8CADC11-8BDA-468E-8616-1915B0B358F8Q37539349-FC5EBBC3-F39A-47E6-BE6D-98608D791E0AQ37626626-755CD968-A71C-464E-A859-E6059A2986C0Q37694773-9E193D0F-8263-4BC2-8B03-1EDBAC2E79ADQ37833109-DC095F1B-2849-41BC-84EA-9572F4A4F8B3Q37985518-6230D8D4-5BE4-4B89-80EA-0B4002911930Q38005913-4084A71C-6DEE-4AE3-8250-44644EE2B200Q38034440-CAE9E35A-50C3-429B-81A5-1D839F82F9CEQ38287178-C629D0B8-5A28-4622-AFD6-7F9F9A4D19D9Q39042894-31268AE7-562A-4FB7-B647-BBC3269F5CAEQ39245623-9F5445BE-0338-47CD-BDC0-B585D836C721Q43080122-EE65EEE3-A89A-4594-AFE6-A1F335DCB52BQ51638287-CED93E1A-B1F3-46EB-A56B-1B76057C234F
P2860
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
@en
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
@nl
type
label
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
@en
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
@nl
prefLabel
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
@en
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
@nl
P2093
P2860
P1476
Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
@en
P2093
Herbert Chen
Muthusamy Kunnimalaiyaan
Susan C Pitt
P2860
P356
10.1016/J.JAMCOLLSURG.2009.03.006
P577
2009-05-01T00:00:00Z